115
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Snuff box radial access in transcatheter arterial embolization for unruptured renal angiomyolipoma

, ORCID Icon, , , , , , , & show all
Pages 27-32 | Received 05 Jun 2019, Accepted 20 Aug 2019, Published online: 19 Sep 2019
 

Abstract

Objective

We report the first three cases in which the feasibility and safety of the left snuff box radial access in transcatheter arterial embolization (TAE) for unruptured renal angiomyolipoma (AML) were evaluated.

Material and methods

Three patients with unruptured renal AMLs underwent TAE via the left snuff box radial artery. We retrospectively evaluated the characteristics of the AMLs, technical success rate, clinical success rate, and complications. Technical success and clinical success were defined as successful insertions of microballoon catheters selectively via the left distal radial artery into all intended arteries in a treatment session and shrinkage of tumor size as evaluated by CT or MRI after the procedure, respectively.

Results

The median size of the renal AMLs was 49 mm. TAE was successfully performed in all cases and all feeding arteries were successfully selected with a microballoon catheter through the left snuff box radial artery. The median amount of the mixture of ethanol and Lipiodol was 1.8 mL. Tumor shrinkage was confirmed in all with a median follow-up period of 6 months. The clinical success rate was 100%. No major complications occurred.

Conclusion

The left snuff box access in TAE for an unruptured renal AML is safe and feasible.

Acknowledgements

The authors thank Dr. Mayura Nakano of the Department of Urology, Tokai University Hachioji Hospital, for their help in patient management; and Dr. Kazunobu Hashida, Dr. and Dr. Satoshi Suda of the Department of Radiology, Tokai University Hachioji Hospital, Tokai University School of Medicine, for continuing support and encouragement.

Declaration of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.